$MOH

Why is Molina Healthcare stock up 3.5% today?

Molina Healthcare (MOH) stock rose 3.8% to $212.09 on pre-earnings optimism and positive sector developments. The company's Q3 2026 earnings are due October 21. The Centers for Medicare & Medicaid Services released 2027 Medicare Advantage Star Ratings, benefiting the sector. Molina also secured new contracts in Illinois and Florida, with the latter expected to generate $6 billion in annual premiums. The broader market slipped slightly.

Original reporting
Published Oct 13, 2026, 5:25 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 5:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMarket movers
Primary signal
$MOH
Bullish
medium confidence
Mentioned
$MOH
Relevance
5/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$MOHBullishMed
01

Why it matters

Today’s rally is framed as a combination of pre-earnings positioning and incremental growth catalysts (Illinois Medicaid contract start, Florida contract expected to scale in Q4 2026) alongside a sector tailwind from CMS 2027 Star Ratings.

02

Market read

Traders may use the CMS Star Ratings and Molina’s contract start milestones to gauge near-term sentiment into the Oct. 21 earnings window.

03

What to watch

The article cites contract start dates and expected premium scale but provides no margin, risk-adjustment, or guidance numbers, leaving uncertainty around how much earnings power the catalysts translate into.

Relevance 5/10Novelty 4/10Timing: mid-day today ahead of Oct. 21 earnings

Background

Molina is a managed-care insurer with Medicare Advantage and Medicaid exposure; CMS Star Ratings influence quality bonus payments and enrollment competitiveness.

Company-level read

Ticker impact

$MOHBullishMedium confidence
Context

Molina Healthcare shares are up intraday as investors position ahead of its Oct. 21 Q3 earnings, supported by CMS 2027 Star Ratings and new Medicaid contracts starting Oct. 1 and in Q4 2026.

Expected impact

Likely continued support while traders price in improved managed-care economics and the upcoming earnings date.

Evidence & confidence

The article attributes today’s move to fresh, Molina-specific contract milestones and a sector tailwind from CMS Star Ratings, but it does not provide a new earnings print or contract award detail beyond start dates and expectations.

Market effects

CMS Star Ratings can shift expectations for quality bonus payments across Medicare Advantage insurers, supporting sentiment in managed care.

Primarily US managed-care and Medicare Advantage enrollment expectations.

Limited direct global spillover; mostly affects US healthcare managed-care risk appetite.

Counterpoint

The move may fade if pre-earnings positioning reverses or if the market interprets the CMS Star Ratings as already priced.

Key entities

  • Molina Healthcare

    Managed-care insurer whose shares are described as rallying ahead of its Oct. 21 Q3 earnings.

  • Centers for Medicare & Medicaid Services (CMS)

    Published 2027 Medicare Advantage Star Ratings, cited as a sector tailwind for quality bonus expectations.

  • Humana

    Peer mentioned as being in focus around the Star Ratings release.

  • Centene

    Peer mentioned as being in focus around the Star Ratings release.

Related articles

$MOHHighAI 8/10

Bernstein reiterates Molina Healthcare stock rating on strong earnings

Bernstein reiterated an Outperform rating and $266 price target for Molina Healthcare (MOH) after strong Q3 2026 earnings. MOH reported adjusted EPS of $0.89, beating estimates by 13%, with premium revenues at $10.46B and total revenues at $11.08B. The company raised its full-year Medicaid cost trend expectation to 5.5%. Analysts from Mizuho and Jefferies also reiterated positive ratings, while Cantor Fitzgerald maintained a Neutral rating.

$MOHMedAI 8/10

MOH Q3 deep dive: Medicaid margin stabilization and rate cycle drive cautious optimism

MOH reported Q3 revenue of $11.08B, beating estimates, with adjusted EPS of $0.89, also above expectations. Management maintained full-year EPS guidance. Medicaid margins stabilized due to rate increases, but membership declined. The company launched a $6B Florida CMS contract, expecting initial losses before break-even. Medicare duals performed well, while Marketplace business is being reduced.

$MOHMedAI 8/10

Mizuho reiterates Molina Healthcare stock rating after Q3 beat

Mizuho reiterated an Outperform rating and $255.00 price target on Molina Healthcare (MOH) after its Q3 2026 earnings beat. The company reported adjusted EPS of $0.89, exceeding estimates of $0.74, driven by premium revenue. MOH stock has gained 24% over six months, trading at $216.64. The company maintained its full-year guidance but noted pressures from Florida contracts and Medicare Advantage losses.

$MOHMed

Molina Healthcare Inc (MOH) (Q3 2026) Earnings Call Highlights: Reaffirmed Guidance

Molina Healthcare (MOH) reported Q3 2026 adjusted pre-tax margin of 0.6% and reaffirmed guidance. Medicaid cost trend rose to 5.5%, and new contracts in Georgia/Texas were delayed. Marketplace and Medicare MAPD segments are expected to lose $0.75 and $1 per share, respectively, in 2026. CEO Joe Zubretsky and CFO Mark Keim discussed Medicaid MLR improvements, Florida CMS contract, and enrollment declines.

$MOHHighAI 8/10

Molina Healthcare Q3 Earnings Call Highlights

Molina Healthcare (MOH) expects its legacy Medicaid business to achieve a 1.6% pretax margin in 2026, with a 6% rate increase projected for 2027. The company anticipates a 6% membership decline in 2027 due to federal work requirements. Its Florida CMS contract, started in Q3, is expected to create a $1.50-per-share earnings drag in 2026. Molina's 2027 premium revenue is projected at $45 billion, down from $46.5 billion. The company's Medicare and Marketplace segments show mixed performance.